These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 33039610

  • 1. Effect of pregnancy and HIV infection on detection of latent TB infection by Tuberculin Skin Test and QuantiFERON-TB Gold In-Tube assay among women living in a high TB and HIV burden setting.
    Birku M, Desalegn G, Kassa G, Tsegaye A, Abebe M.
    Int J Infect Dis; 2020 Dec; 101():235-242. PubMed ID: 33039610
    [Abstract] [Full Text] [Related]

  • 2. Effect of Pregnancy on Interferon Gamma Release Assay and Tuberculin Skin Test Detection of Latent TB Infection Among HIV-Infected Women in a High Burden Setting.
    LaCourse SM, Cranmer LM, Matemo D, Kinuthia J, Richardson BA, Horne DJ, John-Stewart G.
    J Acquir Immune Defic Syndr; 2017 May 01; 75(1):128-136. PubMed ID: 28141782
    [Abstract] [Full Text] [Related]

  • 3. Community-based cross-sectional survey of latent tuberculosis infection in Afar pastoralists, Ethiopia, using QuantiFERON-TB Gold In-Tube and tuberculin skin test.
    Legesse M, Ameni G, Mamo G, Medhin G, Bjune G, Abebe F.
    BMC Infect Dis; 2011 Apr 09; 11():89. PubMed ID: 21477326
    [Abstract] [Full Text] [Related]

  • 4. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
    Wyndham-Thomas C, Dirix V, Schepers K, Martin C, Hildebrand M, Goffard JC, Domont F, Libin M, Loyens M, Locht C, Van Vooren JP, Mascart F.
    BMC Infect Dis; 2015 Feb 14; 15():59. PubMed ID: 25886172
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
    Lin WC, Lin HH, Lee SS, Sy CL, Wu KS, Chen JK, Tsai HC, Chen YS.
    J Microbiol Immunol Infect; 2016 Oct 14; 49(5):729-736. PubMed ID: 25442858
    [Abstract] [Full Text] [Related]

  • 6. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
    Klautau GB, da Mota NVF, Salles MJC, Burattini MN, Rodrigues DS.
    BMC Infect Dis; 2018 Nov 19; 18(1):585. PubMed ID: 30453903
    [Abstract] [Full Text] [Related]

  • 7. Quantitative IFN-γ and IL-2 Response Associated with Latent Tuberculosis Test Discordance in HIV-infected Pregnant Women.
    Mathad JS, Bhosale R, Balasubramanian U, Kanade S, Mave V, Suryavanshi N, Gupte N, Joshi S, Chandanwale A, Dupnik KM, Kulkarni V, Deshpande P, Fitzgerald DW, Gupta A.
    Am J Respir Crit Care Med; 2016 Jun 15; 193(12):1421-8. PubMed ID: 26765255
    [Abstract] [Full Text] [Related]

  • 8. Performance of QuantiFERON-TB Gold In-Tube (QFTGIT) for the diagnosis of Mycobacterium tuberculosis (Mtb) infection in Afar Pastoralists, Ethiopia.
    Legesse M, Ameni G, Mamo G, Medhin G, Bjune G, Abebe F.
    BMC Infect Dis; 2010 Dec 17; 10():354. PubMed ID: 21162756
    [Abstract] [Full Text] [Related]

  • 9. Contribution of interferon gamma release assays testing to the diagnosis of latent tuberculosis infection in HIV-infected patients: a comparison of QuantiFERON-TB Gold In Tube, T-SPOT.TB and tuberculin skin test.
    Ramos JM, Robledano C, Masiá M, Belda S, Padilla S, Rodríguez JC, Gutierrez F.
    BMC Infect Dis; 2012 Jul 31; 12():169. PubMed ID: 22849726
    [Abstract] [Full Text] [Related]

  • 10. Pregnancy differentially impacts performance of latent tuberculosis diagnostics in a high-burden setting.
    Mathad JS, Bhosale R, Sangar V, Mave V, Gupte N, Kanade S, Nangude A, Chopade K, Suryavanshi N, Deshpande P, Kulkarni V, Glesby MJ, Fitzgerald D, Bharadwaj R, Sambarey P, Gupta A.
    PLoS One; 2014 Jul 31; 9(3):e92308. PubMed ID: 24658103
    [Abstract] [Full Text] [Related]

  • 11. Implementing contact tracing for tuberculosis in Kyrgyz Republic and risk factors for positivity using QuantiFERON-TB Gold plus.
    Corbett C, Kulzhabaeva A, Toichkina T, Kalmambetova G, Ahmedov S, Antonenka U, Iskakova A, Kosimova D, Migunov D, Myrzaliev B, Sahalchyk E, Umetalieva N, Vogel M, Kadyrov A, Hoffmann H.
    BMC Infect Dis; 2020 Oct 12; 20(1):746. PubMed ID: 33046016
    [Abstract] [Full Text] [Related]

  • 12. Comparison of QuantiFERON-TB Gold test and tuberculin skin test for the identification of latent Mycobacterium tuberculosis infection in lupus patients.
    Yilmaz N, Zehra Aydin S, Inanc N, Karakurt S, Direskeneli H, Yavuz S.
    Lupus; 2012 Apr 12; 21(5):491-5. PubMed ID: 22140142
    [Abstract] [Full Text] [Related]

  • 13. Interferon Gamma Release Assay and Tuberculin Skin Test Performance in Pregnant Women Living With and Without HIV.
    Kaplan SR, Escudero JN, Mecha J, Richardson BA, Maleche-Obimbo E, Matemo D, Kinuthia J, John-Stewart GC, LaCourse SM.
    J Acquir Immune Defic Syndr; 2022 Jan 01; 89(1):98-107. PubMed ID: 34629414
    [Abstract] [Full Text] [Related]

  • 14. The performance of quantiferon-TB gold in-tube (QFT-IT) test compared to tuberculin skin test (TST) in detecting latent tuberculosis infection (LTBI) in the presence of HIV coinfection in a high TB-burden area with BCG-vaccinated population.
    James PM, Ganaie FA, Kadahalli RL.
    J Int Assoc Provid AIDS Care; 2014 Jan 01; 13(1):47-55. PubMed ID: 23482341
    [Abstract] [Full Text] [Related]

  • 15. Utility of QuantiFERON-TB Gold In-Tube Test in the Diagnosis of Latent TB in HIV-Positive Patients in a Medium-TB Burden Country.
    Khazraiyan H, Liaei ZA, Koochak HE, Ardalan FA, Ahmadinejad Z, Soltani A.
    J Int Assoc Provid AIDS Care; 2016 Jan 01; 15(2):101-6. PubMed ID: 26514628
    [Abstract] [Full Text] [Related]

  • 16. Performance of QuantiFERON-TB Gold Plus for detection of latent tuberculosis infection in pregnant women living in a tuberculosis- and HIV-endemic setting.
    König Walles J, Tesfaye F, Jansson M, Tolera Balcha T, Winqvist N, Kefeni M, Garoma Abeya S, Belachew F, Sturegård E, Björkman P.
    PLoS One; 2018 Jan 01; 13(4):e0193589. PubMed ID: 29617458
    [Abstract] [Full Text] [Related]

  • 17. Evaluating Latent Tuberculosis Infection Test Performance Using Latent Class Analysis in a TB and HIV Endemic Setting.
    Adams S, Ehrlich R, Baatjies R, Dendukuri N, Wang Z, Dheda K.
    Int J Environ Res Public Health; 2019 Aug 14; 16(16):. PubMed ID: 31416206
    [Abstract] [Full Text] [Related]

  • 18. [Comparison of Tuberculin Skin Test (TST) and T-SPOT.TB Tests for Diagnosis of Latent Tuberculosis Infection (LTBI) in HIV-infected Patients].
    Binay UD, Fincancı M, Fersan E, Karakeçili F.
    Mikrobiyol Bul; 2019 Oct 14; 53(4):388-400. PubMed ID: 31709936
    [Abstract] [Full Text] [Related]

  • 19. Tuberculin skin test and QuantiFERON-TB Gold In-tube Test for latent tuberculosis in Thai HIV-infected adults.
    Khawcharoenporn T, Apisarnthanarak A, Phetsuksiri B, Rudeeaneksin J, Srisungngam S, Mundy LM.
    Respirology; 2015 Feb 14; 20(2):340-7. PubMed ID: 25428131
    [Abstract] [Full Text] [Related]

  • 20. Tuberculin test versus interferon gamma release assay in pregnant women with household contacts of tuberculosis patients.
    Chalid MT, Puspawaty D, Tahir AM, Najdah H, Massi MN.
    Int J Mycobacteriol; 2022 Feb 14; 11(4):364-370. PubMed ID: 36510919
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.